April / May #1 : Media - by Mark Schoofs

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Ty Ross Comes Clean

Update: Tom Keane

Asian Denial


Touch Me, Heal Me

What's AIDS got to do with it?


The HIV Beltway

GMHC Goes for a Ride

Things are Looking Up

NIH Names Head of AIDS Research

Voila! AIDS as Art

Philly, the Sequel?

Living Proof


One Voice

MAC to Pass PCP Soon

What Next?

Randy Shilts Dies at 42

Bob Hattoy, On The Record



Alternative Health

Holistic Turnaround

The Sunshine Boys

The Arts



Revis On Top

Eat It, Beat It

HIV Testing Requirements for Entry Into Foreign Countries

HIV Standard of Care

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

April / May 1994


by Mark Schoofs

Whatever happened to the New York Times and AIDS?

The world's most influential newspaper is searching for a new AIDS voice. The New York Times' Jeffrey Schmalz died last November of the disease he covered, but sources at the paper confirm the Times is committed to keeping the beat which the openly HIV positive Schmalz pioneered.

Two cheers. If we get the kind of AIDS journalism Schmalz practiced for most of his career, that's all the Times will deserve. But if the paper continues the course Schmalz set from the grave in his last, posthumously published article, then the Times will have earned a full ovation.

Like the newspaper Schmalz practically personified (he wore bow ties and Oxford shirts and never worked anywhere else), Schmalz publicly entered the AIDS fray late. In 1990, an AIDS-related seizure felled the 17-year Times veteran smack in the middle of the newsroom, thus outing him as both HIV positive and gay. After he recovered, Schmalz asked to write about AIDS and gay rights, and the Times -- under its new, less homophobic leadership -- agreed.

Schmalz excelled at profiles, interviewing such prominent people with AIDS as Mary Fisher, Randy Shilts, Elizabeth Glaser and Magic Johnson (the last, according to longtime friend and USA Today reporter Adam Nagourney, was one of his favorite pieces). In telling the story of AIDS through famous, or at least familiar, people, Schmalz humanized the disease. He made readers who were ignorant, even hostile, more likely to care about the epidemic.

Schmalz was exploring his own predicament, of course, which is what gave his profiles their extra luminosity, like a flash that takes a long time to fade from the mind's eye. In a first-person account published less than a year before he died, Schmalz turned his journalistic spotlight directly on himself, exposing what it was like both to have AIDS and to report on it. In that piece, one of his most memorable, he recalled interviewing Bob Hattoy, one of two people with AIDS to address the Democratic National Convention in the summer of 1992. Hattoy blithely told Schmalz that AIDS "isn't overwhelming me." Schmalz didn't buy it.

I knew from my own experience the nightmares of waking up in a coffin, of wondering whether every cold was the big one that would do me in. I challenged him for not being honest, and he broke down. I wanted to hold him. I wanted to apologize. Then he hit me as hard as I hit him.

"I think I will probably die of AIDS," he blurted out. "Won't you?"

Such passionate writing in the usually dispassionate Times recaptured the media's attention -- albeit briefly -- when tactics such as activists' protests were becoming less and less effective.

What Schmalz didn't do, however, was go after AIDS as Woodward and Bernstein went after Watergate. As one colleague put it, "Jeff reported better on his previous assignments, but he wrote his best on AIDS." The result was a body of work more elegiac than incendiary, more sentimental than useful.

Until, that is, his last piece. In a Sunday magazine cover story titled, "Whatever happened to AIDS?," Schmalz tried to rouse a nation from its complacency, from its defeatist acceptance of AIDS as an immovable "part of the landscape." It was his best piece of work -- urgent and implacable. It didn't aim just to describe the epidemic; it aimed to end the epidemic or at least to shorten it. And it did make an impact. In a speech on World AIDS Day, President Clinton cited the article and concurred with its criticisms, even those of his own Administration.

It was this article which made New Republic editor Andrew Sullivan's memorial tribute to Schmalz, which hit the stands just a day later, jangle so discordantly. "Sometimes," Sullivan wrote, "his anger got the better of his later journalism."


As the effectiveness of his furious last article proves, Schmalz should have channeled more anger into his writing. I don't mean that Schmalz should have become Larry Kramer, screaming without fear or favor. The wrath of a reporter is completely different from the wrath of an activist. A reporter's anger doesn't explode. It's quiet, grim, relentless. A furious activist rants; a furious reporter investigates.

Friends and colleagues say that Schmalz was moving toward exactly this expression of his rage, that if AIDS had given him more time we would have seen more hard-hitting dispatches and investigative reports. In short, more fury and less elegy. More matter and less art. This is the beat and the Schmalz legacy that the Times should continue.

If it does, it could rake a lot of much. As Schmalz's close friend and fellow Times veteran David Dunlap notes, the race for a cure is "an incredibly high-stakes undertaking and one that would richly repay journalistic investigation." Indeed it would as would unraveling why people of color die faster than whites, why gay men have higher rates of KS than other people with AIDS and a thousand other questions, all of which beg one more question: Why haven't the Times and other mainstream papers pursued such stories with the vigor they deserve? After all, as Dunlap points out, the burden of AIDS reporting "shouldn't fall onto a single pair of shoulders."

The top editors at the New York Times, Max Frankel and Joe Lelyveld, declined to be interviewed for this article, but the usual reasons editors give -- that investigative reporting is difficult and expensive -- boil down to this: AIDS still affects mostly gays and people of color, which means that the vast majority of reporters and editors "haven't had anyone close to them die of AIDS," as Nagourney puts it. In this context, Nagourney adds, "Jeff's death was almost as important as his life. This person, who was so much a part of the Times family, died at 39. This was stunning to people."

Maybe, just maybe, it stunned folks at the New York Times enough. When people talk about who the Times will tap as Schmalz's successor, some insist the paper should choose someone else who's HIV positive. Others point out that being gay and a minority is important, as is having a degree in science. But if the paper takes to heart the deepest lessons of Schmalz's life and death, they'll take an HIV negative, straight, white male with any old degree, providing he has just one quality: a reporter's true fury.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.